| Utility: ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING MAGE-A Filling date: 8 Sep 2025 Issue date: 4 Feb 2021 | 30 Jul 2020 | 4 Feb 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 2 Feb 2021 | 30 Jun 2020 | 2 Feb 2021 |
| Utility: Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers Filling date: 8 Sep 2025 Issue date: 2 Feb 2021 | 16 Jun 2020 | 2 Feb 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 2 Feb 2021 | 6 May 2020 | 2 Feb 2021 |
| Utility: Immunotherapy against several tumors including gastrointestinal and gastric cancer Filling date: 8 Sep 2025 Issue date: 2 Feb 2021 | 13 Dec 2019 | 2 Feb 2021 |
| Utility: Immunotherapy against several tumors including neuronal and brain tumors Filling date: 8 Sep 2025 Issue date: 2 Feb 2021 | 2 Aug 2016 | 2 Feb 2021 |
| Utility: ANTI-WT1/HLA-SPECIFIC ANTIBODIES Filling date: 8 Sep 2025 Issue date: 28 Jan 2021 | 13 Oct 2020 | 28 Jan 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 28 Jan 2021 | 13 Oct 2020 | 28 Jan 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NHL AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 28 Jan 2021 | 30 Sep 2020 | 28 Jan 2021 |
| Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, SUCH AS ACUTE MYELOID LEUKEMIA (AML) Filling date: 8 Sep 2025 Issue date: 28 Jan 2021 | 30 Sep 2020 | 28 Jan 2021 |
| Utility: Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 30 Sep 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 11 Sep 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 11 Sep 2020 | 26 Jan 2021 |
| Utility: Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 30 Jun 2020 | 26 Jan 2021 |
| Utility: Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 30 Jun 2020 | 26 Jan 2021 |
| Utility: Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 30 Jun 2020 | 26 Jan 2021 |
| Utility: B*44 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 30 Jun 2020 | 26 Jan 2021 |
| Utility: B*44 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 30 Jun 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 29 Jun 2020 | 26 Jan 2021 |
| Utility: Method of treating with a peptide Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 29 Jun 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 26 Jun 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 26 Jun 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 26 Jun 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 26 Jun 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 26 Jun 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 24 Jun 2020 | 26 Jan 2021 |
| Utility: Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 16 Jun 2020 | 26 Jan 2021 |
| Utility: Immunotherapy against several tumors including gastrointestinal and gastric cancer Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 5 Jun 2020 | 26 Jan 2021 |
| Utility: Method of treating with a peptide Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 29 May 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 17 Apr 2020 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers Filling date: 8 Sep 2025 Issue date: 26 Jan 2021 | 10 Apr 2018 | 26 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 19 Jan 2021 | 5 Apr 2019 | 19 Jan 2021 |
| Utility: NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS OF THE BLOOD, SUCH AS ACUTE MYELOID LEUKEMIA (AML) Filling date: 8 Sep 2025 Issue date: 14 Jan 2021 | 30 Sep 2020 | 14 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 | 18 Jun 2020 | 12 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 | 12 Jun 2020 | 12 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 | 12 Jun 2020 | 12 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 | 12 Jun 2020 | 12 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 | 27 Mar 2020 | 12 Jan 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 | 10 Mar 2020 | 12 Jan 2021 |
| Utility: Transfected T-cells and T-cell receptors for use in immunotherapy against cancers Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 | 9 Mar 2020 | 12 Jan 2021 |
| Utility: Engineered T cell receptors and immune therapy using the same Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 | 7 Jan 2020 | 12 Jan 2021 |
| Utility: Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers Filling date: 8 Sep 2025 Issue date: 12 Jan 2021 | 29 May 2019 | 12 Jan 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 7 Jan 2021 | 26 Jun 2020 | 7 Jan 2021 |
| Utility: METHODS FOR MANUFACTURING T CELLS BY DIRECT SORTING AND COMPOSITIONS THEREOF Filling date: 8 Sep 2025 Issue date: 7 Jan 2021 | 4 Jun 2020 | 7 Jan 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 5 Jan 2021 | 18 Jun 2020 | 5 Jan 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 31 Dec 2020 | 11 Sep 2020 | 31 Dec 2020 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 31 Dec 2020 | 11 Sep 2020 | 31 Dec 2020 |
| Utility: Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) Filling date: 8 Sep 2025 Issue date: 29 Dec 2020 | 24 Jun 2020 | 29 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 29 Dec 2020 | 22 May 2020 | 29 Dec 2020 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 29 Dec 2020 | 1 May 2020 | 29 Dec 2020 |
